Fabrazyme and renal failure 
Fabrazyme and renal failure Patient Reports February 11, 2012
Fabrazyme Side Effects Report #4556933-9
Fabrazyme side effect was reported by a Physician from on Jan 07, 2005. Male patient, 83 years of age, weighting 101.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: base excess negative, c-reactive protein increased, cardiac failure congestive, mitral valve incompetence, pco2 decreased, pneumonia
, po2 decreased, renal failure, tricuspid valve incompetence. Fabrazyme dosage: 45 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, ACETAMINOPHEN, ENALAPRIL MALEATE, PIMOBENDAN, NICORANDIL, ALGINATE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient died on 12/29/2004.Fabrazyme Side Effects Report #6037764-X
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2009. Male patient, 65 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: disease complication, renal failure. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with AMIODARONE. Patient was hospitalized. Patient died on 01/03/2009.
Fabrazyme Side Effects Report #5977548-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on Nov 20, 2008. Male patient, 62 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac ventricular disorder, encephalopathy, renal failure. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4591956-5
Fabrazyme side effect was reported by a Health Professional from on Feb 10, 2005. Female patient, 61 years of age, weighting 149.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: hepatic failure, procedural complication, renal failure. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ATIVAN, BENADRYL, HALDOL. Patient died on 12/22/2004.
Fabrazyme Side Effects Report #4595100-X
Fabrazyme side effect was reported by a Health Professional from on Feb 10, 2005. Female patient, 61 years of age, weighting 149.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: hepatic failure, procedural complication, renal failure, treatment noncompliance. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ATIVAN, BENADRYL, HALDOL. Patient died on 12/22/2004.
Fabrazyme Side Effects Report #4653856-1
Fabrazyme side effect was reported by a Physician from on Apr 20, 2005. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, condition aggravated, diarrhoea, intestinal ischaemia, renal failure, vomiting. Fabrazyme dosage: 1 MG/KG Q2WKS IV; 3 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4673570-6
Fabrazyme side effect was reported by a Health Professional from on May 09, 2005. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dialysis
, diarrhoea, disease progression, intestinal ischaemia, kidney transplant rejection, malaise, renal failure, vomiting. Fabrazyme dosage: 1 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4748479-X
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 05, 2005. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, disease progression, haemodialysis, intestinal ischaemia, kidney transplant rejection, renal failure, vomiting. Fabrazyme dosage: 1 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5944251-3
Fabrazyme side effect was reported by a Physician from UNITED KINGDOM on Oct 22, 2008. Male patient, 58 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure. Fabrazyme dosage: unknown. Patient died on 01/05/2007.
Fabrazyme Side Effects Report #4583502-7
Fabrazyme side effect was reported by a Physician from on Feb 01, 2005. Male patient, 56 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, coronary artery stenosis, disease progression, myocardial infarction, paraesthesia, renal failure, tachyarrhythmia, temperature intolerance, transient ischaemic attack. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with DELIX, ASPIRIN, PLAVIX, NEXIUM, CONCOR, SORTIS. Patient recovered.
Fabrazyme Side Effects Report #4751541-9
Fabrazyme side effect was reported by a Physician from GERMANY on Aug 11, 2005. Male patient, 56 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, coronary artery stenosis, disease recurrence, myocardial infarction, paraesthesia, renal failure, tachyarrhythmia, temperature intolerance. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with DELIX, ASPIRIN, PLAVIX, NEXIUM, CONCOR, SORTIS. Patient recovered.
Fabrazyme Side Effects Report #5227292-3
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2007. Female patient, 52 years of age, weighting 134.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest pain
, dilatation ventricular, disease recurrence, dyspnoea, infusion related reaction, pulmonary arterial pressure increased, renal failure, renal transplant, weight decreased. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with TACROLIMUS, VALGANCICLOVIR, NPH INSULIN, SEPTRA, GABAPENTIN, LISPRO, LORATADINE. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5302363-1
Fabrazyme side effect was reported by a Physician from FRANCE on Apr 05, 2007. Male patient, 52 years of age, weighting 165.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: coronary artery disease
, dialysis , dyspnoea exertional, mediastinitis, oliguria, renal failure, ventricular hypertrophy. Fabrazyme dosage: 70 MG QOW IV. During the same period patient was treated with KARDEGIC, LASIX. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5324218-9
Fabrazyme side effect was reported by a Physician from FRANCE on Apr 25, 2007. Male patient, 52 years of age, weighting 165.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: coronary artery disease
, dialysis , left ventricular hypertrophy, mediastinitis, renal failure. Fabrazyme dosage: 70 MG QOW IV. During the same period patient was treated with KARDEGIC, LASIX. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5503483-9
Fabrazyme side effect was reported by a Physician from FRANCE on Oct 16, 2007. Male patient, 52 years of age, weighting 149.9 lb, was diagnosed with fabry's disease, renal transplant and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthma
, condition aggravated, haemodialysis, hypertension, renal failure, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with PROGRAF, CELLCEPT. Patient recovered.Fabrazyme Side Effects Report #5052859-5
Fabrazyme side effect was reported by a Physician from UNITED STATES on June 28, 2006. Male patient, 51 years of age, weighting 147.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: coronary artery disease
, procedural complication, renal failure. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5713135-8
Fabrazyme side effect was reported by a Physician from JAPAN on Apr 04, 2008. Female patient, 51 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, renal failure. Fabrazyme dosage: 50 MG, Q2W, INTRAVENOUS. During the same period patient was treated with TEMOCAPRIL HYDROCHLORIDE, ALLOPURINOL, ASPIRIN, NITRAZEPAM. Patient recovered.
Fabrazyme Side Effects Report #5147057-0
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Oct 19, 2006. Male patient, 50 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure, white blood cell count abnormal. Fabrazyme dosage: unknown. Patient recovered.
Fabrazyme Side Effects Report #5157108-5
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2006. Male patient, 50 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure. Fabrazyme dosage: unknown. Patient recovered.
Fabrazyme Side Effects Report #5244770-1
Fabrazyme side effect was reported by a Physician from ITALY on Feb 07, 2007. Female patient, 49 years of age, weighting 109.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cachexia, complications of transplanted kidney, gangrene, haemodialysis, renal failure, renal transplant, sepsis
, transplant rejection. Fabrazyme dosage: 1.3 MG/KG Q2WKS; IV. Patient died on 01/01/2007.Fabrazyme Side Effects Report #5121728-4
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 19, 2006. Female patient, 48 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, blood calcium decreased, blood phosphorus increased, blood potassium increased, haemodialysis, hyponatraemia, metabolic acidosis, renal failure. Fabrazyme dosage: 35 MG Q2WKS; IV. During the same period patient was treated with CANDESARTAN CILEXETIL, AMLODIPINE BESYLATE, TEMOCAPRIL HYDROCHLORIDE, DOXAZOSIN MESYLATE. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #5314937-2
Fabrazyme side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Male patient, 46 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anastomotic leak, complications of transplanted kidney, klebsiella infection, renal failure, renal transplant, transplant failure. Fabrazyme dosage: 1 MG/KG QOD IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5319993-3
Fabrazyme side effect was reported by a Physician from UNITED STATES on Apr 25, 2007. Male patient, 46 years of age, weighting 138.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anastomotic leak, complications of transplanted kidney, klebsiella infection, renal failure. Fabrazyme dosage: 1 MG/KG QOD IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5403535-8
Fabrazyme side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, 46 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure, renal transplant. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5408140-5
Fabrazyme side effect was reported by a Physician from JAPAN on July 23, 2007. Male patient, 46 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, cardiomegaly, dilatation ventricular, renal failure, renal transplant. Fabrazyme dosage: 1 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4635830-4
Fabrazyme side effect was reported by a Physician from on Mar 30, 2005. Male patient, 46 years of age, weighting 138.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure. Fabrazyme dosage: unknown. During the same period patient was treated with ULTRAM, ZOLOFT, PHOSLO, PLAVIX, VICODIN, REGLAN, HYDROCODONE BITARTRATE. Patient died on 03/28/2005.
Fabrazyme Side Effects Report #4571922-6
Fabrazyme side effect was reported by a Physician from on Jan 20, 2005. Male patient, 45 years of age, weighting 150.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, haemodialysis, post procedural nausea, post procedural vomiting, renal failure, treatment noncompliance, tremor. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with NORVASC, TOPROL, ALBUTEROL, PAXIL, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5284192-0
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Male patient, 44 years of age, weighting 138.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: burning sensation, limb discomfort, renal failure. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5293688-7
Fabrazyme side effect was reported by a Physician from FRANCE on Mar 27, 2007. Male patient, 44 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiomegaly, cerebrovascular accident, renal failure. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5320646-6
Fabrazyme side effect was reported by a Physician from UNITED STATES on Apr 19, 2007. Male patient, 44 years of age, weighting 138.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: burning sensation, limb discomfort, paraesthesia, renal failure, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with TYLENOL, BENADRYL, KYTRIL, ARANESP. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #5147065-X
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2006. Male patient, 44 years of age, weighting 123.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chronic allograft nephropathy, glomerular filtration rate decreased, renal failure. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with PREDNISONE, PROGRAF, CELLCEPT. Patient recovered.
Fabrazyme Side Effects Report #4793939-9
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 22, 2005. Male patient, 44 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure, sepsis
. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient died on 09/24/2005.Fabrazyme Side Effects Report #5673021-9
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Mar 03, 2008. Male patient, 40 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: adverse event, anxiety
, chest discomfort, dialysis , disease recurrence, feeling abnormal, renal failure. Fabrazyme dosage: 75 MG, INTRAVENOUS. Patient recovered.Fabrazyme Side Effects Report #5673052-9
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Mar 03, 2008. Male patient, 40 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: adverse event, anxiety
, chest discomfort, feeling abnormal, renal failure. Fabrazyme dosage: 75 MG, INTRAVENOUS. Patient recovered.Fabrazyme Side Effects Report #5369961-0
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Male patient, 39 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure. Fabrazyme dosage: 1 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5430343-4
Fabrazyme side effect was reported by a Physician from GERMANY on Aug 15, 2007. Male patient, 39 years of age, weighting 146.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, renal failure, renal transplant, sepsis
, skin laceration, somnolence. Fabrazyme dosage: 75 MG Q2WKS IV. During the same period patient was treated with COTRIM, VALCYTE, PANTOPRAZOLE, FORLAX, TEGRETOL, MORPHINE SULPHATE, MYFORTIC, HALOPERIDOL. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5625444-1
Fabrazyme side effect was reported by a Health Professional from UNITED KINGDOM on Jan 28, 2008. Male patient, 39 years of age, weighting 176.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: acute prerenal failure, clostridium difficile colitis, hypovolaemia, poor venous access. Fabrazyme dosage: 80 MG, Q2W, INTRAVENOUS; 70 MG, Q2W, INTRAVENOUS; 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #6084756-0
Fabrazyme side effect was reported by a Physician from FRANCE on Jan 26, 2009. Male patient, 39 years of age, weighting 130.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angioedema, blister, blood pressure increased, bronchospasm, eyelid oedema, oropharyngeal discomfort, paraesthesia, renal failure, respiratory disorder. Fabrazyme dosage: 1 MG/KG,Q2W; INTRAVENOUS. During the same period patient was treated with IRBESARTAN, TRANDOLAPRIL, ARARAX, PARACETAMOL, PREDNISONE. Patient recovered.
Fabrazyme Side Effects Report #6035285-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 02, 2009. Female patient, 38 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: influenza, kidney transplant rejection, pyelonephritis, renal disorder, renal failure, weight increased. Fabrazyme dosage: 65 MG, Q2W, INTRAVENOUS. Patient recovered.
Fabrazyme Side Effects Report #5725869-X
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 15, 2008. Male patient, 37 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: fluid retention, haemodialysis, renal failure, renal impairment, renal transplant. Fabrazyme dosage: 60 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5735384-5
Fabrazyme side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Male patient, 37 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: fluid retention, haemodialysis, renal failure, renal impairment, renal transplant. Fabrazyme dosage: 50 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4978219-0
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Apr 04, 2006. Male patient, 37 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: fluid retention, haemodialysis, renal failure, renal impairment. Fabrazyme dosage: 60 MG Q2WKS IV. During the same period patient was treated with TYLENOL, BENADRYL. Patient recovered.
Fabrazyme Side Effects Report #5810640-0
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 27, 2008. Male patient, 36 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest pain
, disease progression, peritoneal dialysis complication, renal failure. Fabrazyme dosage: 75 MG. Q2W. INTRAVENOUS. During the same period patient was treated with GABAPENTIN, TEGRETOL, BENADRYL, ACETAMINOPHEN. Patient recovered.Fabrazyme Side Effects Report #5388747-4
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Male patient, 34 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure. Fabrazyme dosage: 55 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5222532-9
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 11, 2007. Male patient, 33 years of age, weighting 227.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure, renal transplant. Fabrazyme dosage: 85 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5302366-7
Fabrazyme side effect was reported by a Physician from JAPAN on Apr 02, 2007. Male patient, 32 years of age, weighting 112.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, haemodialysis, renal failure, renal transplant. Fabrazyme dosage: 50 MG Q2WKS IV. During the same period patient was treated with CARBAMAZEPINE, AMLODIPINE BESYLATE, MYCOPHENOLATE MOFETIL, TACROLIMUS HYDRATE, ASPIRIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4726184-3
Fabrazyme side effect was reported by a Physician from JAPAN on July 11, 2005. Male patient, 32 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: haemodialysis, renal failure, renal transplant. Fabrazyme dosage: 50 MG Q2WKS IV. During the same period patient was treated with EPOETIN BETA, CARBAMAZEPINE, CALCITRIOL, SPHERICAL ABSORBENT COAL, PRECIPITATED CALCIUM CARBONATE, NAHCO, AMLODIPINE BESYLATE, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5231994-2
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 23, 2007. Male patient, 30 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: catheter related infection, klebsiella infection, pancreatitis relapsing, peritoneal dialysis, peritonitis, pseudocyst, renal failure, staphylococcal infection
, treatment noncompliance. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with PRILOSEC, COZAAR, LASIX, REGLAN. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5145003-7
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2006. Male patient, 30 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dialysis
, pancreatitis, renal failure, treatment noncompliance. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5189865-6
Fabrazyme side effect was reported by a Physician from UNITED STATES on Dec 05, 2006. Male patient, 30 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: catheter related infection, haemodialysis, klebsiella infection, pancreatitis relapsing, peritoneal fluid analysis abnormal, peritonitis, pseudocyst, renal failure, staphylococcal infection
. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with PRILOSEC, COZAAR, LASIX, REGLAN. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5484988-6
Fabrazyme side effect was reported by a Physician from UNITED STATES on Oct 03, 2007. Female patient, weighting 250.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: disease recurrence, fatigue, malaise, peritoneal dialysis, renal failure, renal pain, stomach discomfort. Fabrazyme dosage: unknown. During the same period patient was treated with BENADRYL, TYLENOL, INCORPORATED. Patient recovered.
Fabrazyme Side Effects Report #5674052-5
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Mar 03, 2008. Male patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arteriovenous fistula operation, renal failure. Fabrazyme dosage: unknown. Patient recovered.
Fabrazyme Side Effects Report #5674057-4
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Mar 03, 2008. Male patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dialysis
, renal failure. Fabrazyme dosage: unknown. Patient recovered.Fabrazyme Side Effects Report #5699430-X
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Mar 26, 2008. Male patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, renal failure, renal transplant. Fabrazyme dosage: 43 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5710575-8
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2008. Male patient was diagnosed with fabry's disease, infection
and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , renal failure, white blood cell count decreased. Fabrazyme dosage: 45 MG, Q2W, INTRAVENOUS. During the same period patient was treated with VALCYTE. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #6025853-5
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2008. Female patient, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure, transplant failure. Fabrazyme dosage: 65 MG, Q2W, INTRAVENOUS. Patient recovered.